What is Forward Pharma A/S (FWPAY) stock price today?

Forward Pharma A/S (FWPAY) is currently trading at $300.00, down 25.09% today.

What is FWPAY P/E ratio?

Forward Pharma A/S's P/E ratio is 2166.67. This is above the market average, reflecting high growth expectations.

What is FWPAY return on equity (ROE)?

Forward Pharma A/S's return on equity (ROE) is 0.12%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is Forward Pharma A/S's market cap?

Forward Pharma A/S has a market capitalization of $7.45M.

OTC · Biotechnology

Forward Pharma A/S (FWPAY) Stock

$300.00 -25.09% OTC: FWPAY Healthcare

Forward Pharma A/S presently engages in very limited business activities. In the past, this biopharmaceutical firm concentrated its efforts on developing FP187, its distinctive formulation of dimethyl fumarate, which was aimed at addressing both inflammatory and neurological conditions.

Valuation

Metric	Value
Price	$300.00
Market Cap	$7.45M
P/E Ratio	2166.67
P/B Ratio	2.69
P/S Ratio	0.00
EPS (TTM)	$0.14
52-Week High	$882.86
52-Week Low	$200.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	0.12%
ROA	0.13%
ROCE	-5.47%
Gross Margin	100.00%
Operating Margin	—
Net Margin	-47.87%
Debt/Equity	0.00
Current Ratio	117.44

Annual Financials (USD)

Metric	2017	2018	2019	2020	2021
Revenue	$1.3B	$0	$0	$0	$0
Operating Profit	$1.2B	$-12.0M	$-5.0M	$-3.0M	$-4.0M
Net Profit	$917.0M	$-9.0M	$-4.0M	$-6.0M	$-2.0M
EPS	$38845.06	$-368.51	$-177.58	$-268.72	$-77.41
Op Margin	95.0%	—	—	—	—

Balance Sheet (USD)

Metric	2017	2018	2019	2020	2021
Total Assets	$111.0M	$83.0M	$78.0M	$80.0M	$71.0M
Total Liabilities	$21.0M	$1.0M	$1.0M	$1.0M	$1.0M
Cash	$110.0M	$83.0M	$78.0M	$79.0M	$71.0M
Borrowings	$0	$0	$0	$0	$0

Latest News

Hyundai Motor reports 21% drop in Q2 operating profit, misses forecasts Reuters · Jul 23, 2026 Asian stocks rise as AI capex ramps up, oil at six-week highs Reuters · Jul 23, 2026 TenPay Global Named to CNBC's World's Top Fintech Companies 2026 List PR Newswire · Jul 23, 2026 Besi posts sharp rise in quarterly orders Reuters · Jul 23, 2026 Nokia provides recast comparative financial information reflecting the presentation of Fixed Wireless Access CPE and Enterprise Campus Edge businesses as discontinued operations GlobeNewswire · Jul 23, 2026

Cash Flow (USD)

Metric	2017	2018	2019	2020	2021
Operating Cash Flow	$940.0M	$-15.0M	$-2.0M	$-6.0M	$-2.0M
Investing Cash Flow	$85.0M	$0	$0	$0	$0
Financing Cash Flow	$-25.0M	$-8.0M	$-1.0M	$0	$0
Net Cash Flow	$52.0M	$-27.0M	$-5.0M	$1.0M	$-8.0M
Free Cash Flow	$940.0M	$-15.0M	$-2.0M	$-6.0M	$-2.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	21.67
EV / EBITDA	37.40
FCF Yield	-26.86%
Quick Ratio	117.44
Interest Coverage	1.95
Return 1Y	—
Return 3Y	—
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
BNOEFBionomics Limited	$0.01	-14.89%	-0.30	$8.81M	0.00%
CRBKFCarebook Technologies Inc.	$0.03	+0.00%	-0.15	$6.84M	0.00%
FLWPFThe Flowr Corporation	$0.00	—	—	$4265	0.00%
HBCNFHealthBeacon plc	$0.50	+2269.67%	-0.56	$8.44M	0.00%
IMUNImmune Therapeutics, Inc.	$0.09	-7.00%	-0.56	$7.78M	0.00%

About Forward Pharma A/S

Forward Pharma A/S is headquartered in DK.

Forward Pharma A/S (FWPAY) stock trades at $300.00 with a market capitalization of $7.45M. The stock is valued at a price-to-earnings (P/E) ratio of 2166.67, price-to-book of 2.69, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $200.00 and $882.86, and currently trades 66.0% below its 52-week high.

On profitability, Forward Pharma A/S generates a return on equity (ROE) of 0.12%, return on capital employed of -5.47%, a net profit margin of -47.87%.

Official website: www.forward-pharma.com

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides